Roundup Cancer Lawsuit & Toxic-Tort Claims After the Supreme Court Overturned a 2024 Missouri Verdict on FIFRA Preemption Grounds — Attorney911 Pursues Bayer-Monsanto on Surviving Design-Defect, Negligence and Off-Label Marketing Theories When Label-Based Failure-to-Warn Is Now Barred, the Glyphosate Exposure That Causes Non-Hodgkin Lymphoma Through a Multi-Year Latency Window Still Actionable Beyond the Label, Ralph Manginello’s 27+ Years of Federal-Court Trial Practice, Lupe Peña the Former Insurance-Defense Insider Who Knows How the Claims Machine Values and Denies Toxic-Tort Cases After $10 Billion in Prior Roundup Payouts, We Preserve Exposure Histories, Purchase Receipts and Oncology Records Before the Statute of Limitations Runs, the Firm Has Recovered $50M+ for Injury Victims — Free 24/7 Consultation, No Fee Unless We Win, Hablamos Español, 1-888-ATTY-911
Missouri Roundup Cancer Lawsuits After the Supreme Court Ruling: What Survives, What Does Not, and What You Should Do Right Now You heard the news. The Supreme Court ruled for Bayer. A Missouri verdict was thrown out. And now you are sitting at a kitchen table at 2 a.m. wondering whether the case you were counting on — the case that was supposed to answer for the cancer that upended your life — is dead. We are writing this page for that exact moment. The answer is not what the headlines made it sound like. The ruling is real. It eliminated one legal theory. It did not eliminate your case. And the difference between those two things is everything. Here is what actually happened on June 25, 2026: the United States Supreme Court held that a federal pesticide law called FIFRA — the Federal Insecticide, Fungicide, and Rodenticide Act — preempts state-law claims that demand a cancer warning on the Roundup label. The court overturned a 2024 Missouri jury verdict that had awarded $1.25 million to a man who used Roundup and developed blood cancer. That part is true. But plaintiff counsel in the Roundup litigation stated plainly after the ruling that it “only impacts cases that are based on failure-to-warn in the pesticide labels” — and does not bar claims based on defective design, negligence, or warnings communicated outside the label through advertising and marketing. Bayer has already paid more than $10 billion to resolve prior claims. More than…